Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selective SIRT2 inhibitors as promising anticancer therapeutics: An update from 2016 to 2020

18 Jul 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to PARP inhibition in cancer therapy
Share to Sirtuins and Resveratrol in Medicine

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34303869
DOI: 10.1016/j.ejmech.2021.113709

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Selective SIRT2 inhibitors as promising anticancer therapeutics: An update from 2016 to 2020PMID 34303869Read ↗

Selective inhibition of SIRT2: A disputable therapeutic approach in cancer therapySemantic proximity Read ↗

Identification of a novel SIRT7 inhibitor as anticancer drug candidateSemantic proximity Read ↗

A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer ActivitySemantic proximity Read ↗

A review on SIRT3 and its natural small molecule activators as a potential Preventive and therapeutic targetSemantic proximity Read ↗

Structure, functions, and recent advances in the development of SIRT2 inhibitorsSemantic proximity Read ↗

Recent Progress on the Discovery of Sirt2 Inhibitors for the Treatment of Various CancersSemantic proximity Read ↗

Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effectSemantic proximity Read ↗

The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extensionSemantic proximity Read ↗

SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2Semantic proximity Read ↗

The Role of SIRT1 in CancerSemantic proximity Read ↗

Identification of Tri‐ and Tetracyclic Pyrimidinediones as Sirtuin InhibitorsSemantic proximity Read ↗

Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)- N -phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.